Podcasts about caprie

Welcome to the Transatlantic series, a co-production of Audible Bleeding (a publication of the SVS) and the ESVS podcast. In today's episode, we explore the intersocietal guidelines on peripheral arterial disease in patients with diabetes and foot ulcers authored by the International Working Group on the Diabetic Foot (IWGDF), the European Society for Vascular Surgery (ESVS), and the Society for Vascular Surgery (SVS).   Dr. Robert Fitridge is a Professor of Vascular Surgery at University of Adelaide in Australia. He is a member of the IWGDF and is also a member of the steering committee for the Global Vascular Guideline on the management of Chronic Limb-threatening Ischaemia.    Dr. Vivienne Chuter is a Professor in the Department of Podiatry at Western Sydney University and Honorary Professor in the School of Health Science at The University of NewCastle. She is a member of the IWGDF. She has published extensively on diabetic foot disease and leads a clinically based research program focusing on the prevention and management of diabetes-related foot disease for Aboriginal and Torres Strait Islander people and for non-Indigenous Australians.   Dr. Nicolaas Schaper is an emeritus professor of Endocrinology at Maastricht University Hospital in the Netherlands. Dr. Schaper was the coordinator of the European diabetic foot research consortium, Eurodiale. He is Chair of the 2023 Diabetic Foot Symposium (ISDF 2023) and is Chair of the IWGDF.   Dr. Joseph L. Mills is a Professor of Vascular Surgery at Baylor in Houston, Texas. He is a member of the IWGDF. Dr. Mills is a leader in the vascular surgery global community, has served as president of the Peripheral Vascular Surgery Society, and is currently a member of the Surgery Residency Review Committee of the ACGME.   Further reading and links:   The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer. Global vascular guidelines for CLTI Best-CLI Engaging patients and caregivers to establish priorities for the management of diabetic foot ulcers A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial Release of the National Scheme's Aboriginal and Torres Strait Islander Health and Cultural Safety Strategy 2020-2025; the impacts for podiatry in Australia: a commentary Editor's Choice - European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases Results of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events Low-Dose Aspirin for the Primary Prevention of Cardiovascular Disease in Diabetic Individuals: A Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis Diabetes, Lower-Extremity Amputation, and Death Outcomes in patients with chronic leg wounds in Denmark: A nationwide register‐based cohort study Pedal arch patency and not direct-angiosome revascularization predicts outcomes of endovascular interventions in diabetic patients with critical limb ischemia Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: A systematic review.  Performance of non-invasive bedside vascular testing in the prediction of wound healing or amputation among people with foot ulcers in diabetes: A systematic review. Effectiveness of revascularisation for the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI). Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial.   Mobile Applications:   Society for Vascular Surgery Mobile App for Staging of Chronic Limb-Threatening Ischemia.  European Society for Vascular Surgery Clinical Practice Guidelines Mobile Edition.   Hosts:    Dr. Naveed A. Rahman is a chief surgery resident at SUNY Upstate in Syracuse, NY. He will pursue a vascular surgery fellowship at the University of Maryland starting in 2024. His Doximity profile is https://www.doximity.com/pub/naveed-rahman-md. Twitter: @naveedrahmanmd Dr. Suzanne Stokmans is a fifth-year vascular surgery resident at the Isala Hospital in Zwolle, the Netherlands. Dr. Ezra Schwartz is a medical graduate from McGill University currently completing a Master of Medical Science in Medical Education at Harvard Medical School. He is an aspiring vascular surgeon and surgical education researcher. Twitter: @ezraschwartz10   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

Welcome to the Transatlantic Series, a co-production of Audible Bleeding (a publication of the SVS) and the ESVS podcast. In today's episode, we explore the intersocietal guidelines on peripheral arterial disease in patients with diabetes and foot ulcers authored by the International Working Group on the Diabetic Foot, the European Society for Vascular Surgery, and the Society for Vascular Surgery.Dr. Robert Fitridge is a Professor of Vascular Surgery at University of Adelaide in Australia. He is a member of the IWGDF and a member of the steering committee for the Global Vascular Guideline on the management of Chronic Limb-threatening Ischaemia. Dr. Vivienne Chuter is a Professor in the Department of Podiatry at Western Sydney University and Honarary Professor in the School of Health SCiences at The University of NewCastle. She is a member of the IWGDF. She has published extensively on diabetic foot disease and leads a clinically based research program focusing on prevention and management of diabetes-related foot disease for Aboriginal and Torres Strait Islander people and for non-Indigenous Australians.Dr. Nicolaas Schaper is emeritus professor of Endocrinology at Maastricht University Hospital in the Netherlands. Dr. Schaper was coordinator of the European diabetic foot research consortium, Eurodiale. He is Chair of the 2023 Diabetic Foot Symposium and is Chair of the IWGDF.Dr. Joseph L. Mills is a Professor of Vascular Surgery at Baylor in Houston, Texas. He is a member of the IWGDF. Dr. Mills is a leader in the vascular surgery global community, has served as president of the Peripheral Vascular Surgery Society and is currently a member of the Surgery Residency Review Committee of the ACGME.Further reading:The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer.Global vascular guidelines for CLTIBest-CLIEngaging patients and caregivers to establish priorities for the management of diabetic foot ulcersA systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcersA vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trialRelease of the National Scheme's Aboriginal and Torres Strait Islander Health and Cultural Safety Strategy 2020-2025; the impacts for podiatry in Australia: a commentaryESVS 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular DiseasesResults of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic eventsLow-Dose Aspirin for the Primary Prevention of Cardiovascular Disease in Diabetic Individuals: A Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis*Diabetes, Lower-Extremity Amputation, and DeathHosts: Dr. Naveed A. Rahman is chief surgery resident at SUNY Upstate in Syracuse, NY. He will be pursuing vascular surgery fellowship at University of Maryland starting in 2024. His Doximity profile is www.doximity.com/pub/naveed-rahman-md. X: @naveedrahmanmdDr. Suzanne Stokmans is a 5th year vascular surgery resident in the Isala hospital in Zwolle, the Netherlands.Dr. Ezra Schwartz is a medical graduate from McGill University currently completing a Masters of Medical Science in Medical Eduation at Harvard Medical School. He is an aspiring vascular surgeon and surgical education researcher. X: @ezraschwartz10

MedLink Neurology Podcast is delighted to feature selected episodes from BrainWaves, courtesy of James E Siegler MD, its originator and host. BrainWaves is an academic audio podcast whose mission is to educate medical providers through clinical cases and topical reviews in neurology, medicine, and the humanities, and episodes originally aired from 2016 to 2021.Originally released: Jan 18, 2018When it comes to stroke, treatment is dependent on the stroke mechanism. But most patients wind up on aspirin anyway. Or Plavix (clopidogrel). And sometimes both. The question this week is, Why? I hope you're hungry for some fruit because we're comparing a bunch of apples to oranges in this episode of the BrainWaves podcast.Produced by James E Siegler. Music by William Ross Chernoff's Nomads, Steve Combs, Rui, Little Glass Men, and Peter Rudenko. Voiceover by Erika Mejia. BrainWaves' podcasts and online content are intended for medical education only and should not be used for routine clinical decision-making. Even if this episode is all about choosing aspirin or clopidogrel when you're treating stroke patients. Always talk with your doctor, and if you are a doctor, you should rely on institutional policies and your own clinical judgment when treating patients.REFERENCESAntithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324(7329):71-86. Erratum in: BMJ 2002;324(7330):141. PMID 11786451Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354(16):1706-17. PMID 16531616CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997;349(9066):1641-9. PMID 9186381Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308(6921):81-106. Erratum in: BMJ 1994;308(6943):1540. PMID 8298418CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348(9038):1329-39. PMID 8918275Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004;364(9431):331-7. PMID 15276392Hong KS, Lee SH, Kim EG, et al. Recurrent ischemic lesions after acute atherothrombotic stroke: clopidogrel plus aspirin versus aspirin alone. Stroke 2016;47(9):2323-30. PMID 27418597Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44(3):870-947. PMID 23370205Kennedy J, Hill MD, Ryckborst KJ, et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 2007;6(11):961-9.

Anna Costamagna is an Italian Interior Design Manager working at Peugeot and Advanced Design Manager for Stellantis. While her mother worked as an assistant to Sergio Pininfarina, she began her career at Bertone in Caprie, a suburb of her native Turin, after studying engineering and management. She then moved to Paris, France, to bring Peugeot production cars to fruition. Over her career, Costamagna has worked with a number of companies to develop future-looking concepts as well as groundbreaking interior proposals, including the Peugeot i-Cockpit. Form Trends editor Eric Gallina spoke with Costamagna about her career path, the projects she's worked on, interface design, and also discussed diversity in the workplace as well as the role of the designer and manager in the corporate environment.Support the show (https://www.patreon.com/formtrends)

October 29 is World Stroke Day! Might as well know how it is best treated. This week, Jim Siegler revisits a 2017 episode on the differences between two of the most commonly prescribed post-stroke treatments, with some key updates, recent trial results, and practice-changing paradigms. Produced by James E. Siegler. Music courtesy of William Ross Chernoff’s Nomads, Steve Combs, Rui, Little Glass Men, and Peter Rudenko. The opening theme was composed by Jimothy Dalton. Sound effects by Mike Koenig and Daniel Simion. Unless otherwise mentioned in the podcast, no competing financial interests exist in the content of this episode. BrainWaves' podcasts and online content are intended for medical education only and should not be used for clinical decision making. Be sure to follow us on Twitter @brainwavesaudio for the latest updates to the podcast. REFERENCES Jauch EC, Saver JL, Adams HP, Jr., Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW, Jr., Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H, American Heart Association Stroke C, Council on Cardiovascular N, Council on Peripheral Vascular D and Council on Clinical C. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke; a journal of cerebral circulation. 2013;44:870-947. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet. 1997;349:1569-81. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet. 1997;349:1641-9. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM and Investigators F. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. The Lancet Neurology. 2007;6:961-9. Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, Wang C, Li H, Meng X, Cui L, Jia J, Dong Q, Xu A, Zeng J, Li Y, Wang Z, Xia H, Johnston SC and Investigators C. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. The New England journal of medicine. 2013;369:11-9. Hong KS, Lee SH, Kim EG, Cho KH, Chang DI, Rha JH, Bae HJ, Lee KB, Kim DE, Park JM, Kim HY, Cha JK, Yu KH, Lee YS, Lee SJ, Choi JC, Cho YJ, Kwon SU, Kim GM, Sohn SI, Park KY, Kang DW, Sohn CH, Lee J, Yoon BW and Investigators C. Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone. Stroke; a journal of cerebral circulation. 2016;47:2323-30. Liu L, Wong KS, Leng X, Pu Y, Wang Y, Jing J, Zou X, Pan Y, Wang A, Meng X, Wang C, Zhao X, Soo Y, Johnston SC, Wang Y and Investigators C. Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE. Neurology. 2015;85:1154-62. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. Bmj. 1994;308:81-106. Antithrombotic Trialists C. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Bmj. 2002;324:71-86. Committee CS. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329-39. Ringleb PA, Bhatt DL, Hirsch AT, Topol EJ, Hacke W and Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events I. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke; a journal of cerebral circulation. 2004;35:528-32. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ and investigators M. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-7. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ and Investigators C. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. The New England journal of medicine. 2006;354:1706-17. Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JF, Wilson M, Mehta Z and Meade TW. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet. 2012;379:1602-12. Sahlen A, Varenhorst C, Lagerqvist B, Renlund H, Omerovic E, Erlinge D, Wallentin L, James SK and Jernberg T. Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry. European heart journal. 2016;37:3335-3342. Bath PM, Woodhouse LJ, Appleton JP, Beridze M, Christensen H, Dineen RA, Duley L, England TJ, Flaherty K, Havard D, Heptinstall S, James M, Krishnan K, Markus HS, Montgomery AA, Pocock SJ, Randall M, Ranta A, Robinson TG, Scutt P, Venables GS, Sprigg N and Investigators T. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. Lancet. 2018;391:850-859. Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, Averkov O, Bahit MC, Berwanger O, Budaj A, Hijazi Z, Parkhomenko A, Sinnaeve P, Storey RF, Thiele H, Vinereanu D, Granger CB, Alexander JH and Investigators A. Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation. The New England journal of medicine. 2019;380:1509-1524. Wang Y, Chen W, Lin Y, Meng X, Chen G, Wang Z, Wu J, Wang D, Li J, Cao Y, Xu Y, Zhang G, Li X, Pan Y, Li H, Zhao X, Liu L, Lin J, Dong K, Jing J, Johnston SC, Wang D, Wang Y and Group PPS. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial. Bmj. 2019;365:l2211.

Alberto Milesi"Borgate dal Vivo"http://www.borgatedalvivo.it/Sabato 27 giugno riparte Borgate dal Vivo 2020il primo festival delle borgate e dei piccoli comuni alpini30 eventi in 27 comuni tra Piemonte, Valle D'Aosta, Liguria, Lombardiadal 27 giugno al 6 settembre 2020Tra i tanti ospiti: Niccolò Fabi in dialogo con Saverio Tommasi; un'anteprima di Francesco Montanari; il debutto di Quattro Donne di Chiara Buratti; Nicolò Govoni; Andrea Scanzi; Mauro Corona; Dario Ballantini; Guido Catalano; Mauro Berruto; Tommaso RagnoIl 27 giugno, con un evento trasmesso in diretta dalla sacra di San Michele, monumento simbolo del Piemonte, riparte Borgate dal Vivo che, in un momento storico particolarmente complesso, ha scelto come titolo della V edizione un verso iconico di Dante: “A riveder le stelle”.Borgate dal Vivo è il primo festival delle borgate e dei piccoli comuni alpini, che porta grandi eventi di spettacolo - tra teatro, musica, letteratura, cinema e circo - sull'arco alpino occidentale. Sin dalla sua nascita, Borgate dal Vivo si prende cura dei luoghi periferici proponendo bellezza e ha come scopo l'innovazione sociale e culturale di zone lontane dai grandi centri urbani, valorizzando lo straordinario patrimonio naturalistico e architettonico dei piccoli borghi, tra i quali Oulx, Avigliana, Venaus, Borgata Celle di Caprie in provincia di Torino; Borgo Viatosto in provincia di Asti; Valtournenche in provincia di Aosta e Madesimo in provincia di Sondrio. L'emergenza sanitaria ha rimesso in gioco il settore dello spettacolo dal vivo, ma la rassegna favorisce da sempre l'incontro non caotico in luoghi accoglienti e magici, nei quali il pubblico potrà assistere agli spettacoli in totale sicurezza.Borgate dal Vivo è anche il festival più grande d'Italia per estensione e durata: quasi tre mesi di appuntamenti, dal 27 giugno al 6 settembre 2020, per 30 eventi in 27 diversi comuni tra Liguria, Piemonte e Valle D'Aosta.“A rivedere le stelle” è un'espressione di riapertura, ripartenza, rinascita. Un ritorno alla vita insieme, nel rispetto rigoroso delle norme che richiederanno il mantenimento del distanziamento sociale minimo. Per questa ragione, la prima serata del festival sarà trasmessa gratuitamente in diretta sul canale Facebook di Borgate dal Vivo e sarà l'unico evento del calendario del festival senza pubblico, in attesa di poter tornare alle modalità solite, sempre nel massimo rispetto delle direttive.Protagonisti della serata saranno la violinista Elisabetta Bosio e l'attore Saulo Lucci. Per riprendere il payoff della quinta edizione del festival, Saulo Lucci declamerà l'ultimo canto dell'Inferno di Dante, che termina proprio con il verso “A riveder le stelle”. A seguire, Elisabetta Bosio eseguirà musiche di Elizabeth Lounge Project, ovvero suoi brani originali, e ci sarà anche spazio per un omaggio al Maestro Ezio Bosso. Tra i tanti ospiti in programma per la V edizione: Niccolò Fabi (venerdì 24 luglio a Bussoleno, TO), incontrerà Saverio Tommasi per un dialogo sui diritti umani. La sua canzone “Io sono l'altro” - da “Tradizione e tradimento” pubblicato a ottobre 2019 - è la vincitrice per il 2020 del Premio Amnesty International Italia. Sarà un incontro tra musica e parole durante il quale racconterà la sua esperienza a fianco di Medici con l'Africa CUAMM e Associazione Nazionale Italiana Cantanti, realtà con cui da sempre collabora attivamente. E poi: l'anteprima di un nuovo monologo di Francesco Montanari (sabato 25 luglio ad Avigliana, TO) ispirato ai “Menecmi” di Plauto: due fratelli gemelli, separati alla nascita, che si rincontrano dopo lunghe peripezie dando origine ad una serie di scambi di persone e dunque di equivoci; il debutto di Quattro Donne, ultimo spettacolo di Chiara Buratti (mercoledì 5 agosto ad Asti), incentrato sulle figure di quattro donne molto diverse da loro, ma unite da una sensibilità fuori dal comune; lo scrittore e attivista Nicolò Govoni, Premio CIDU per i Diritti Umani 2020, che da anni dedica la sua vita al sostegno e alla tutela dei diritti dei minori, presenterà in anteprima il suo ultimo libro in uscita a settembre per Trigono Edizioni (sabato 22 agosto ad Oulx, TO); Andrea Scanzi con il suo spettacolo su Giorgio Gaber; e ancora Mauro Corona; Dario Ballantini; Guido Catalano; Mauro Berruto. Non mancheranno produzioni originali, come un evento su Dracula di Bram Stoker con la straordinaria voce di Tommaso Ragno. Confermato anche il consueto appuntamento sui cambiamenti climatici con Luca Mercalli, uno dei temi centrali del festival Borgate dal Vivo. La serata di apertura del 27 giugno promuoverà una raccolta fondi a sostegno della Sacra di San Michele, messa in seria difficoltà, come molti altri luoghi, dalla chiusura prolungata degli ultimi mesi. Borgate dal Vivo è un progetto di Associazione RevejoRealizzato con il sostegno di Regione Piemonte, Fondazione CRT, Fondazione CRC e “Comuni in Rete”Sponsor: Fondazione Time2, NovacoopIl programma è disponibile sul sito www.borgatedalvivo.itI biglietti degli eventi a pagamento saranno in vendita sui circuiti Vivaticket e Piemonteticket a partire dall'inizio del mese di luglio. Per gli eventi gratuiti sarà necessario prenotarsi sul sito www.borgatedalvivo.it, in ragione degli accessi contingentati e per permettere la fruizione in totale sicurezza. Sarà possibile prenotarsi anche via Facebook, sulle varie pagine dei singoli eventi.IL POSTO DELLE PAROLEascoltare fa pensarehttps://ilpostodelleparole.it/

✅ E' stata pubblicata oggi la graduatoria degli interventi a sostegno dell'ediliza scolastica nei plessi piemontesi che saranno inseriti nella programmazione triennale 2018-2020, finanziati dalla European Investment Bank. Ce ne sono 57 e tra questi il liceo Darwin di Rivoli, il Liceo Classico G. F. Porporato e il Liceo Artistico Buniva di Città di Pinerolo e alcune scuole di Saluzzo✅ L'approfondimento sarà dedicato all'intenso weekend di Borgate dal vivo che si snoderà tra Oulx, Caprie, in Val Susa e Madesimo, in provincia di Sondrio✅ Il Governo stoppa la Regione Piemonte: saltano 200 milioni destinati alle imprese, l'ira di Chiamparino✅ Gli appuntamenti migliori della serata in Piemonte scelti per voi

When it comes to stroke, treatment is dependent on the stroke mechanism. But most patients wind up on aspirin anyway. Or Plavix (clopidogrel). And sometimes both. The question this week is, Why? Hope you're hungry for some fruit. We're comparing a bunch of apples to oranges in this episode of the BrainWaves podcast. Produced by James E. Siegler. Music by William Ross Chernoff's Nomads, Steve Combs, Rui, Little Glass Men, and Peter Rudenko. Voiceover by Erika Mejia. BrainWaves' podcasts and online content are intended for medical education only and should not be used for routine clinical decision making. Even if this episode is all about choosing aspirin or clopidogrel when you're treating stroke patients. Always talk with your doctor, and if you are a doctor, you should rely on institutional policies and your own clinical judgment when treating patients. REFERENCES Jauch EC, Saver JL, Adams HP, Jr., Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW, Jr., Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H, American Heart Association Stroke C, Council on Cardiovascular N, Council on Peripheral Vascular D and Council on Clinical C. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke; a journal of cerebral circulation. 2013;44:870-947. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet. 1997;349:1569-81. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet. 1997;349:1641-9. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM and Investigators F. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. The Lancet Neurology. 2007;6:961-9. Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, Wang C, Li H, Meng X, Cui L, Jia J, Dong Q, Xu A, Zeng J, Li Y, Wang Z, Xia H, Johnston SC and Investigators C. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. The New England journal of medicine. 2013;369:11-9. Hong KS, Lee SH, Kim EG, Cho KH, Chang DI, Rha JH, Bae HJ, Lee KB, Kim DE, Park JM, Kim HY, Cha JK, Yu KH, Lee YS, Lee SJ, Choi JC, Cho YJ, Kwon SU, Kim GM, Sohn SI, Park KY, Kang DW, Sohn CH, Lee J, Yoon BW and Investigators C. Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone. Stroke; a journal of cerebral circulation. 2016;47:2323-30. Liu L, Wong KS, Leng X, Pu Y, Wang Y, Jing J, Zou X, Pan Y, Wang A, Meng X, Wang C, Zhao X, Soo Y, Johnston SC, Wang Y and Investigators C. Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE. Neurology. 2015;85:1154-62. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. Bmj. 1994;308:81-106. Antithrombotic Trialists C. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Bmj. 2002;324:71-86. Committee CS. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329-39. Ringleb PA, Bhatt DL, Hirsch AT, Topol EJ, Hacke W and Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events I. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke; a journal of cerebral circulation. 2004;35:528-32. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ and investigators M. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-7. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ and Investigators C. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. The New England journal of medicine. 2006;354:1706-17. Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JF, Wilson M, Mehta Z and Meade TW. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet. 2012;379:1602-12.

Caprie è stato uno dei comuni più colpiti dagli incendi di ottobre: il consorzio delle librerie indipendenti torinesi (Colti) ha deciso di devolvere i proventi dalla vendita di "L'uomo che piantava gli alberi" al rimboschimento del territorio bruciato.L'intervista a Davide Ferraris, responsabile della comunicazione del consorzio

I fronti alti degli incendi dell'area Cumiana-Cantalupa hanno interessato i 7 confini, dunque la zona del giavenese.Dal punto di vista delle priorità, i punti più critici sono quelli che rischiano l’esposizione delle case e degli abitanti. L’altra zona è quella della zona di Mompantero che ormai è sotto le pendici del Rocciamelone e Caprie, anche nel verso il parco del Gran Paradiso dove i fronti sono in via di espansione. Nel cuneese i fronti sono molto estesi, 15 km sul Sambuco e sul valico di confine dell’Argentera.L’incendio di Roure continua a covare, tutto in sotterranea, ogni tanto ha delle riprese, c’è stato in zona Perrero. La reazione è stata immediata ma purtroppo parliamo di gestione di questo incendio, non è pensabile parlare di estinzione e andare a casa a riposarsi.

I fronti alti degli incendi dell'area Cumiana-Cantalupa hanno interessato i 7 confini, dunque la zona del giavenese.Dal punto di vista delle priorità, i punti più critici sono quelli che rischiano l’esposizione delle case e degli abitanti. L’altra zona è quella della zona di Mompantero che ormai è sotto le pendici del Rocciamelone e Caprie, anche nel verso il parco del Gran Paradiso dove i fronti sono in via di espansione. Nel cuneese i fronti sono molto estesi, 15 km sul Sambuco e sul valico di confine dell’Argentera.L’incendio di Roure continua a covare, tutto in sotterranea, ogni tanto ha delle riprese, c’è stato in zona Perrero. La reazione è stata immediata ma purtroppo parliamo di gestione di questo incendio, non è pensabile parlare di estinzione e andare a casa a riposarsi.

La situazione nel comune di Caprie, in Val Susa